vs
AMERICAN SHARED HOSPITAL SERVICES（AMS）与FLEXIBLE SOLUTIONS INTERNATIONAL INC（FSI）财务数据对比。点击上方公司名可切换其他公司
FLEXIBLE SOLUTIONS INTERNATIONAL INC的季度营收约是AMERICAN SHARED HOSPITAL SERVICES的1.2倍（$9.1M vs $7.7M），FLEXIBLE SOLUTIONS INTERNATIONAL INC净利率更高（-5.1% vs -8.2%，领先3.1%），FLEXIBLE SOLUTIONS INTERNATIONAL INC同比增速更快（-0.5% vs -14.8%），AMERICAN SHARED HOSPITAL SERVICES自由现金流更多（$-2.7M vs $-4.0M），过去两年AMERICAN SHARED HOSPITAL SERVICES的营收复合增速更高（21.7% vs -0.6%）
美国共享医院服务公司为医疗机构提供放射治疗、立体定向放射外科及诊断成像设备的整体外包解决方案，免除医院高昂的前期资本投入，主要业务覆盖北美，同时服务拉美及部分亚太地区的公立、私立医院客户。
Flexible Solutions International Inc是一家专注研发生产特种化学品的企业，核心产品包括水体蒸发抑制剂、农作物增产助剂、泳池保温剂等，服务北美及全球农业、水务领域客户。
AMS vs FSI — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.7M | $9.1M |
| 净利润 | $-631.0K | $-460.9K |
| 毛利率 | 11.7% | 29.4% |
| 营业利润率 | -18.1% | 11.6% |
| 净利率 | -8.2% | -5.1% |
| 营收同比 | -14.8% | -0.5% |
| 净利润同比 | 52.5% | -167.8% |
| 每股收益（稀释后） | $-0.09 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $7.7M | $9.1M | ||
| Q3 25 | $7.2M | $10.6M | ||
| Q2 25 | $7.1M | $11.4M | ||
| Q1 25 | $6.1M | $7.5M | ||
| Q4 24 | $9.1M | $9.2M | ||
| Q3 24 | $7.0M | $9.3M | ||
| Q2 24 | $7.1M | $10.5M | ||
| Q1 24 | $5.2M | $9.2M |
| Q4 25 | $-631.0K | $-460.9K | ||
| Q3 25 | $-17.0K | $-503.4K | ||
| Q2 25 | $-280.0K | $2.0M | ||
| Q1 25 | $-625.0K | $-277.7K | ||
| Q4 24 | $-1.3M | $679.6K | ||
| Q3 24 | $-207.0K | $611.9K | ||
| Q2 24 | $3.6M | $1.3M | ||
| Q1 24 | $119.0K | $457.2K |
| Q4 25 | 11.7% | 29.4% | ||
| Q3 25 | 22.1% | 23.9% | ||
| Q2 25 | 23.1% | 47.4% | ||
| Q1 25 | 15.4% | 26.1% | ||
| Q4 24 | 35.3% | 29.2% | ||
| Q3 24 | 19.6% | 40.9% | ||
| Q2 24 | 35.0% | 37.4% | ||
| Q1 24 | 41.1% | 30.6% |
| Q4 25 | -18.1% | 11.6% | ||
| Q3 25 | -4.8% | 2.9% | ||
| Q2 25 | -7.7% | 29.0% | ||
| Q1 25 | -21.3% | -0.9% | ||
| Q4 24 | -20.2% | 9.4% | ||
| Q3 24 | -12.7% | 20.5% | ||
| Q2 24 | -0.0% | 18.7% | ||
| Q1 24 | -1.6% | 8.3% |
| Q4 25 | -8.2% | -5.1% | ||
| Q3 25 | -0.2% | -4.8% | ||
| Q2 25 | -4.0% | 17.8% | ||
| Q1 25 | -10.2% | -3.7% | ||
| Q4 24 | -14.6% | 7.4% | ||
| Q3 24 | -3.0% | 6.6% | ||
| Q2 24 | 51.0% | 12.3% | ||
| Q1 24 | 2.3% | 5.0% |
| Q4 25 | $-0.09 | $-0.03 | ||
| Q3 25 | $0.00 | $-0.04 | ||
| Q2 25 | $-0.04 | $0.15 | ||
| Q1 25 | $-0.10 | $-0.02 | ||
| Q4 24 | $-0.21 | $0.05 | ||
| Q3 24 | $-0.03 | $0.05 | ||
| Q2 24 | $0.55 | $0.10 | ||
| Q1 24 | $0.02 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | — |
| 总债务越低越好 | $17.4M | $4.4M |
| 股东权益账面价值 | $24.0M | $38.9M |
| 总资产 | $55.5M | $61.8M |
| 负债/权益比越低杠杆越低 | 0.72× | 0.11× |
8季度趋势，按日历期对齐
| Q4 25 | $3.5M | — | ||
| Q3 25 | $5.1M | — | ||
| Q2 25 | $11.1M | $10.0M | ||
| Q1 25 | $11.2M | $11.0M | ||
| Q4 24 | $11.0M | $10.0M | ||
| Q3 24 | $13.8M | $13.0M | ||
| Q2 24 | $14.2M | $9.2M | ||
| Q1 24 | $12.8M | $8.3M |
| Q4 25 | $17.4M | $4.4M | ||
| Q3 25 | $18.2M | $7.1M | ||
| Q2 25 | $19.1M | $7.5M | ||
| Q1 25 | $19.9M | $8.1M | ||
| Q4 24 | $20.4M | $8.8M | ||
| Q3 24 | $14.4M | $9.4M | ||
| Q2 24 | $15.1M | $8.3M | ||
| Q1 24 | $15.6M | $8.0M |
| Q4 25 | $24.0M | $38.9M | ||
| Q3 25 | $24.6M | $39.0M | ||
| Q2 25 | $24.5M | $39.4M | ||
| Q1 25 | $24.6M | $38.4M | ||
| Q4 24 | $25.2M | $38.0M | ||
| Q3 24 | $26.4M | $36.9M | ||
| Q2 24 | $26.5M | $36.2M | ||
| Q1 24 | $22.8M | $36.0M |
| Q4 25 | $55.5M | $61.8M | ||
| Q3 25 | $59.6M | $58.4M | ||
| Q2 25 | $63.5M | $58.2M | ||
| Q1 25 | $63.3M | $61.7M | ||
| Q4 24 | $60.2M | $60.0M | ||
| Q3 24 | $63.3M | $57.8M | ||
| Q2 24 | $60.8M | $56.3M | ||
| Q1 24 | $50.1M | $57.6M |
| Q4 25 | 0.72× | 0.11× | ||
| Q3 25 | 0.74× | 0.18× | ||
| Q2 25 | 0.78× | 0.19× | ||
| Q1 25 | 0.81× | 0.21× | ||
| Q4 24 | 0.81× | 0.23× | ||
| Q3 24 | 0.54× | 0.25× | ||
| Q2 24 | 0.57× | 0.23× | ||
| Q1 24 | 0.68× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-704.0K | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | $-2.7M | $-4.0M |
| 自由现金流率自由现金流/营收 | -34.8% | -44.3% |
| 资本支出强度资本支出/营收 | 25.7% | 11.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.5M | $-591.7K |
8季度趋势，按日历期对齐
| Q4 25 | $-704.0K | $-3.0M | ||
| Q3 25 | $1.7M | $2.0M | ||
| Q2 25 | $-372.0K | $5.3M | ||
| Q1 25 | $2.5M | $-544.3K | ||
| Q4 24 | $274.0K | $-2.2M | ||
| Q3 24 | $472.0K | $2.5M | ||
| Q2 24 | $1.3M | $5.9M | ||
| Q1 24 | $-1.9M | $-604.8K |
| Q4 25 | $-2.7M | $-4.0M | ||
| Q3 25 | $-2.0M | $39.4K | ||
| Q2 25 | $-2.3M | $4.3M | ||
| Q1 25 | $-1.5M | $-898.4K | ||
| Q4 24 | $-4.4M | $-4.3M | ||
| Q3 24 | $-407.0K | $1.3M | ||
| Q2 24 | $70.0K | $4.7M | ||
| Q1 24 | $-3.0M | $-1.1M |
| Q4 25 | -34.8% | -44.3% | ||
| Q3 25 | -28.3% | 0.4% | ||
| Q2 25 | -32.1% | 37.9% | ||
| Q1 25 | -24.7% | -12.0% | ||
| Q4 24 | -48.4% | -47.0% | ||
| Q3 24 | -5.8% | 13.6% | ||
| Q2 24 | 1.0% | 44.9% | ||
| Q1 24 | -58.4% | -11.7% |
| Q4 25 | 25.7% | 11.7% | ||
| Q3 25 | 51.6% | 18.7% | ||
| Q2 25 | 26.9% | 8.6% | ||
| Q1 25 | 65.7% | 4.7% | ||
| Q4 24 | 51.4% | 22.8% | ||
| Q3 24 | 12.6% | 13.0% | ||
| Q2 24 | 17.2% | 11.3% | ||
| Q1 24 | 22.7% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.60× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.27× | ||
| Q3 24 | — | 4.05× | ||
| Q2 24 | 0.36× | 4.59× | ||
| Q1 24 | -15.67× | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMS
| Direct Patient Services | $4.0M | 51% |
| Rental Income From Medical Services | $2.7M | 35% |
| Pbrt Services | $1.2M | 15% |
FSI
暂无分部数据
